ALLERGAN IS UNCUT GEM IN SMITHKLINE BEECHAM MERGER; SPIN-OFF GUARANTEES SHAREHOLDER VALUE -- FIRM IS CANDIDATE FOR LEVERAGED BUYOUT, PURCHASE OFFERS